Muramyl dipeptide-elicited production of PGD2 from astrocytes in culture.
Yamamoto. K K; Miwa. T T; Ueno. R R; Hayaishi. O O
Key Findings
- Muramyl dipeptide (MDP), lipopolysaccharide (LPS), and interleukin‑1 (IL‑1) strongly increase PGD2 release from astrocytes.
- Delta‑sleep‑inducing peptide (DSIP) and uridine do not stimulate PGD2 release in this model.
- PGD2 may be a downstream mediator in the sleep‑promoting effects of MDP, LPS, and IL‑1.
Practical Outcomes
- For biohackers using DSIP for sleep, this study suggests DSIP does not boost PGD2, so its sleep benefits likely come from other mechanisms. It highlights that immune‑related compounds can raise PGD2, but translating that into a safe, effective protocol for humans would require much more research.
Summary
In rat brain cell experiments, substances that trigger immune responses (muramyl dipeptide, LPS, and IL‑1) made the cells release a sleep‑related molecule called PGD2, while the peptide DSIP and uridine did not cause this release. This suggests PGD2 is part of how some immune signals promote sleep, but DSIP probably works through a different route.
Abstract
We used primary cultures of rat brain astroglial cells in order to investigate the interrelationship between PGD2 and other sleep-promoting substances such as muramyl dipeptide (MDP), lipopolysaccharide (LPS), delta-sleep-inducing peptide (DSIP), uridine, and interleukin 1 (IL-1). A large amount of PGD2 was released into the culture medium by stimulation with MDP, LPS, and IL-1 but DSIP and uridine failed to stimulate such release. These results suggest that PGD2 may be part of the series of biochemical steps involved in induction of sleep by MDP, LPS, and IL-1.
Study Information
pubmed
1988
1988-10-31T00:00:00.000Z
10.1016/s0006-291x(88)80926-4